Author Archives for Atlanpole Biotherapies

New member | L’Oeil Electrique

12 August 2020

L’OEIL ELECTRIQUE is an audiovisual production agency that produces video content for business communication. LOE SANTÉ is part of LOEIL... View Article

New member | Hoppen

12 August 2020

HOPPEN develops technological tools and solutions intended to support hospitals and clinics in their digital transformation, providing concrete responses to... View Article

Owkin Closes Series A Round to Deploy Federated Learning for Research at Scale, with a Total of $70M Raised

12 August 2020

  Series A round closed with an $18 million commitment from Mubadala Investment Company’s asset management arm, Mubadala Capital in... View Article

The CE4BIG project: A European project federating four major clusters in the healthcare sector

12 August 2020

The French Atlanpole Biotherapies in Nantes is federating four major healthcare clusters aimed at fostering business growth in SMEs specialising... View Article

XENOTHERA secures funding of its anti-Covid treatment, and accelerates its product portfolio by a total amount of more than 7 million euros

12 August 2020

XENOTHERA, a Nantes-based biotech created in 2014, today announced that it has been awarded 2.3 million euros by the French Government,... View Article

i-SEP has obtained authorisations from ANSM and AFMPS to launch its clinical trial in France and Belgium

12 August 2020

I-SEP, a French MedTech (Nantes) specialising in blood processing and Patient Blood Management, has developed and patented a pioneering technology... View Article

GoLiver Therapeutics Receives a Positive Scientific Advice from the European Medicines Agency (EMA)

12 August 2020

GoLiver Therapeutics Receives a Positive Scientific Advice from the European Medicines Agency (EMA) on its Clinical Development and Biomanufacturing Strategy... View Article

#Coronavirus | AtlanChim Pharma: special offer on fine Organic chemistry supporting Covid-19 Research

12 August 2020

📣 In these extraordinary circumstances ATLANCHIM PHARMA wishes to collaborate with developers of small molecules based COVID-19 #covid #chemistry For your request... View Article

New member – Vetbiobank

12 August 2020

Vetbiobank is a veterinary french biotech specialized since 2011 in the development and manufacturing of innovative animal cell-based drugs for... View Article

Hera-MI launches subsidiary in the United States

12 August 2020

Hera-MI announces the creation of its subsidiary in the United States “Hera-MI Corp.” Since November 2019, Hera-MI has been the... View Article